These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15657350)
1. (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Oliver CL; Miranda MB; Shangary S; Land S; Wang S; Johnson DE Mol Cancer Ther; 2005 Jan; 4(1):23-31. PubMed ID: 15657350 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. Lin J; Wu Y; Yang D; Zhao Y Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869 [TBL] [Abstract][Full Text] [Related]
3. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death. Shangary S; Johnson DE Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. Ballestrero A; Nencioni A; Boy D; Rocco I; Garuti A; Mela GS; Van Parijs L; Brossart P; Wesselborg S; Patrone F Clin Cancer Res; 2004 Feb; 10(4):1463-70. PubMed ID: 14977850 [TBL] [Abstract][Full Text] [Related]
5. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells. Sun J; Li ZM; Hu ZY; Lin XB; Zhou NN; Xian LJ; Yang DJ; Jiang WQ Anticancer Drugs; 2008 Nov; 19(10):967-74. PubMed ID: 18827561 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H; Bouchon A; Stahl H; Krammer PH Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456 [TBL] [Abstract][Full Text] [Related]
7. Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. Lei X; Chen Y; Du G; Yu W; Wang X; Qu H; Xia B; He H; Mao J; Zong W; Liao X; Mehrpour M; Hao X; Chen Q FASEB J; 2006 Oct; 20(12):2147-9. PubMed ID: 16935937 [TBL] [Abstract][Full Text] [Related]
8. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma. Mohammad RM; Wang S; Aboukameel A; Chen B; Wu X; Chen J; Al-Katib A Mol Cancer Ther; 2005 Jan; 4(1):13-21. PubMed ID: 15657349 [TBL] [Abstract][Full Text] [Related]
9. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells. Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010 [TBL] [Abstract][Full Text] [Related]
10. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Voss V; Senft C; Lang V; Ronellenfitsch MW; Steinbach JP; Seifert V; Kögel D Mol Cancer Res; 2010 Jul; 8(7):1002-16. PubMed ID: 20587533 [TBL] [Abstract][Full Text] [Related]
11. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells. Han CR; Jun do Y; Lee JY; Kim YH Apoptosis; 2014 Jan; 19(1):224-40. PubMed ID: 24166139 [TBL] [Abstract][Full Text] [Related]
12. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. Ko CH; Shen SC; Yang LY; Lin CW; Chen YC Int J Cancer; 2007 Oct; 121(8):1670-9. PubMed ID: 17597109 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Zhang M; Liu H; Guo R; Ling Y; Wu X; Li B; Roller PP; Wang S; Yang D Biochem Pharmacol; 2003 Jul; 66(1):93-103. PubMed ID: 12818369 [TBL] [Abstract][Full Text] [Related]
14. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Wang P; Song JH; Song DK; Zhang J; Hao C Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262 [TBL] [Abstract][Full Text] [Related]
15. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365 [TBL] [Abstract][Full Text] [Related]
16. (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells. Meng Y; Li Y; Li J; Li H; Fu J; Liu Y; Liu H; Chen X Leuk Lymphoma; 2007 Nov; 48(11):2204-12. PubMed ID: 17926190 [TBL] [Abstract][Full Text] [Related]
17. Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways. Zhang M; Liu H; Tian Z; Griffith BN; Ji M; Li QQ Life Sci; 2007 Jan; 80(8):767-74. PubMed ID: 17156797 [TBL] [Abstract][Full Text] [Related]
18. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. Gao G; Dou QP J Cell Biochem; 2000 Sep; 80(1):53-72. PubMed ID: 11029754 [TBL] [Abstract][Full Text] [Related]
19. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Xu L; Yang D; Wang S; Tang W; Liu M; Davis M; Chen J; Rae JM; Lawrence T; Lippman ME Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891 [TBL] [Abstract][Full Text] [Related]
20. Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems. Etxebarria A; Landeta O; Antonsson B; Basañez G Biochem Pharmacol; 2008 Dec; 76(11):1563-76. PubMed ID: 18762177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]